Neuroprotective effects of oxytocin against ischemic stroke in rats by blocking glutamate release and CREB-mediated DNA hypermethylation

Xin-Yu Fan; Guang Shi; Yun-Peng Zhao; Jing-Jing Yang; Juan Feng

doi:10.1016/j.biopha.2023.115520

Neuroprotective effects of oxytocin against ischemic stroke in rats by blocking glutamate release and CREB-mediated DNA hypermethylation

Biomed Pharmacother. 2023 Nov:167:115520. doi: 10.1016/j.biopha.2023.115520. Epub 2023 Sep 18.

Authors

Xin-Yu Fan¹, Guang Shi², Yun-Peng Zhao¹, Jing-Jing Yang¹, Juan Feng³

Affiliations

¹ Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.
² Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China; Department of Neurology, The People's Hospital of Liaoning Province, Shenyang, China.
³ Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: juanfeng@cmu.edu.cn.

PMID: 37729734
DOI: 10.1016/j.biopha.2023.115520

Abstract

Glutamate plays a crucial role in cognitive impairments after ischemic stroke. There is a scarcity of information about how glutamate-induced activation of cAMP-response element binding (CREB) signaling pathway regulates both the negative and positive regulators of synaptic plasticity. Recent studies have demonstrated the involvement of prominent epigenetic repressors, such as MeCP2 and DNMTs, in stroke. Neuroprotective effects of oxytocin against ischemia have been previously reported, while the underlying mechanism is still elusive. In this research, the possible role of CREB-mediated DNA hypermethylation and the potential mechanism of oxytocin in a rat model of permanent middle cerebral artery occlusion (pMCAO) were assessed. Adult male Sprague-Dawley rats were pretreated with intraperitoneal injection of oxytocin at the onset of pMCAO. The effects of oxytocin on spines and the expression levels of synaptic genes were determined. The regulatory effects of oxytocin on glutamate level, N-methyl-D-aspartate receptors (NMDARs), its downstream CREB pathway, and global or gene-specific DNA methylation status were evaluated by immunofluorescence, co-immunoprecipitation, and chromatin immunoprecipitation, respectively. We found that CREB could act as a common transcription factor for MeCP2 and DNMT3B after ischemic stroke. Oxytocin dose-dependently deactivated NR2B-related CaM-CREB pathway and inhibited DNA hypermethylation at the CpG islands of Ngf gene in pMCAO-operated rats. Moreover, oxytocin prevented pMCAO-induced reduction in the number of spines and neural cells. DNA hypermethylation in Ngf gene contributed to the cognitive deficits post-stroke. The neuroprotective effects of oxytocin against ischemia could be attributed to inhibiting glutamate release, providing additional evidence on the mechanism of oxytocin against ischemic stroke.

Keywords: CREB; DNA methylation; Glutamate; Oxytocin; Permanent middle cerebral artery occlusion.